EP2503338
CD73 sem lífmerki til að fylgjast með framgangi sjúkdóma og meta skilvirkni lækningameðferðar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.10.2008EP published:
24.12.2014EP application number:
12002502.8
EP translation filed:
24.2.2015Grant published:
15.3.2015EPO information:
European Patent Register
Max expiry date:
14.10.2028Expiry date:
14.10.2024
Title:
CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
Timeline
Today
15.10.2008EP application
24.12.2014EP Publication
24.2.2015Translation submitted
15.3.2015Registration published
14.10.2024Expires
Owner
Name:
Faron Pharmaceuticals OYAddress:
Tykistökatu 6 B, 20520, Turku, FI
Inventor
Name:
Jalkanen, SirpaAddress:
Piispanristi, FI
Name:
Salmi, MarkoAddress:
Turku, FI
Name:
jalkanen, MarkkuAddress:
Piispanristi, FR
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
20070795Date:
24.10.2007Country:
FI
Classification
Categories:
G01N 33/573, C07K 14/705, C12N 9/16, G01N 33/574
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 22.10.2015
Expires: 14.10.2016
Payer: Árnason Faktor
Number: 9
Paid: 26.10.2016
Expires: 14.10.2017
Payer: Árnason Faktor
Number: 10
Paid: 30.10.2017
Expires: 14.10.2018
Payer: Árnason Faktor
Number: 11
Paid: 18.10.2018
Expires: 14.10.2019
Payer: Árnason Faktor
Number: 12
Paid: 21.10.2019
Expires: 14.10.2020
Payer: Árnason Faktor
Number: 13
Paid: 27.10.2020
Expires: 14.10.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 25.10.2021
Expires: 14.10.2022
Payer: CPA Global (Patrafee) AB
Number: 15
Paid: 24.10.2022
Expires: 14.10.2023
Payer: CPA Global (Patrafee) AB
Number: 16
Paid: 17.10.2023
Expires: 14.10.2024
Payer: CPA Global (Patrafee) AB